Literature DB >> 30758754

Thyroid Gland Solitary Fibrous Tumor: Report of 3 Cases and a Comprehensive Review of the Literature.

Lester D R Thompson1, Christina Wei2, Lisa M Rooper3, Sean K Lau4.   

Abstract

Solitary fibrous tumors of the thyroid gland are exceptionally rare. In order to further characterize the clinical and pathologic features of solitary fibrous tumor arising at this anatomic site, three cases of thyroid gland solitary fibrous tumor were analyzed in conjunction with 35 cases compiled from the English literature. Thyroid gland solitary fibrous tumors showed an equal sex distribution with a mean age at presentation of 54.4 years (range, 28-88 years). The patients typically presented with an asymptomatic, slow growing neck mass. Microscopically, the tumors were characterized by cytologically bland spindle cells with patternless growth, hypocellular and hypercellular areas, variable amounts of collagen, and ectatic, branching blood vessels. Two previous reported tumors were considered to be histologically malignant on the basis of increased mitotic activity, profound pleomorphism and tumor necrosis. Immunohistochemically, the tumor cells are variably positive with CD34, bcl-2, and CD99. STAT6 immunohistochemistry, performed on the current cases, demonstrated a strong, diffuse nuclear expression in all tumors. Among 26 patients with available follow up data (mean 47.3 months), one developed local recurrence and distant metastasis. Solitary fibrous tumors occurring in the thyroid gland are uncommon, but can be reliably diagnosed based on the presence of characteristic morphologic features as well as immunohistochemical expression of STAT6 and CD34. The majority of thyroid gland solitary fibrous tumors have exhibited an indolent clinical course, however experience is limited. The rare potential for aggressive clinical behavior requires clinical surveillance.

Entities:  

Keywords:  Follow-up studies; Immunohistochemistry; Neoplasms, vascular tissue; STAT6; Solitary fibrous tumors; Thyroid gland

Mesh:

Year:  2019        PMID: 30758754      PMCID: PMC6854167          DOI: 10.1007/s12105-019-01012-6

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  60 in total

1.  Extensive survey of STAT6 expression in a large series of mesenchymal tumors.

Authors:  Elizabeth G Demicco; Paul W Harms; Rajiv M Patel; Steven C Smith; Davis Ingram; Keila Torres; Shannon L Carskadon; Sandra Camelo-Piragua; Jonathan B McHugh; Javed Siddiqui; Nallasivam Palanisamy; David R Lucas; Alexander J Lazar; Wei-Lien Wang
Journal:  Am J Clin Pathol       Date:  2015-05       Impact factor: 2.493

2.  Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor.

Authors:  Arezoo Mohajeri; Johnbosco Tayebwa; Anna Collin; Jenny Nilsson; Linda Magnusson; Fredrik Vult von Steyern; Otte Brosjö; Henryk A Domanski; Olle Larsson; Raf Sciot; Maria Debiec-Rychter; Jason L Hornick; Nils Mandahl; Karolin H Nord; Fredrik Mertens
Journal:  Genes Chromosomes Cancer       Date:  2013-06-12       Impact factor: 5.006

3.  Clinicopathological and genetic heterogeneity of the head and neck solitary fibrous tumours: a comparative histological, immunohistochemical and molecular study of 36 cases.

Authors:  Yu-Chien Kao; Po-Chun Lin; Shao-Lun Yen; Shih-Chiang Huang; Jen-Wei Tsai; Chien-Feng Li; Hui-Chun Tai; Jui Lan; I-Chieh Chuang; Shih-Chen Yu; Hsuan-Ying Huang
Journal:  Histopathology       Date:  2015-08-17       Impact factor: 5.087

Review 4.  Solitary fibrous tumor of the head and neck.

Authors:  Darren P Cox; Troy Daniels; Richard C K Jordan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-05-21

5.  Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics.

Authors:  Leona A Doyle; Marina Vivero; Christopher Dm Fletcher; Fredrik Mertens; Jason L Hornick
Journal:  Mod Pathol       Date:  2013-09-13       Impact factor: 7.842

6.  STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors.

Authors:  Akihiko Yoshida; Koji Tsuta; Makoto Ohno; Masayuki Yoshida; Yoshitaka Narita; Akira Kawai; Hisao Asamura; Ryoji Kushima
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

7.  STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics.

Authors:  Alison L Cheah; Steven D Billings; John R Goldblum; Paula Carver; Munir Z Tanas; Brian P Rubin
Journal:  Pathology       Date:  2014-08       Impact factor: 5.306

8.  Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour.

Authors:  Christian Koelsche; Leonille Schweizer; Marcus Renner; Arne Warth; David T W Jones; Felix Sahm; David E Reuss; David Capper; Thomas Knösel; Birte Schulz; Iver Petersen; Alexis Ulrich; Eva Kristin Renker; Burkhard Lehner; Stefan M Pfister; Peter Schirmacher; Andreas von Deimling; Gunhild Mechtersheimer
Journal:  Histopathology       Date:  2014-09-02       Impact factor: 5.087

9.  Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.

Authors:  Dan R Robinson; Yi-Mi Wu; Shanker Kalyana-Sundaram; Xuhong Cao; Robert J Lonigro; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Rui Wang; Fengyun Su; Matthew K Iyer; Sameek Roychowdhury; Javed Siddiqui; Kenneth J Pienta; Lakshmi P Kunju; Moshe Talpaz; Juan Miguel Mosquera; Samuel Singer; Scott M Schuetze; Cristina R Antonescu; Arul M Chinnaiyan
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

10.  Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.

Authors:  Juliann Chmielecki; Aimee M Crago; Mara Rosenberg; Rachael O'Connor; Sarah R Walker; Lauren Ambrogio; Daniel Auclair; Aaron McKenna; Michael C Heinrich; David A Frank; Matthew Meyerson
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

View more
  7 in total

1.  Two case reports of rare diseases occurring in rare parts: splenic vein solitary fibrous tumor and liver solitary fibrous tumor.

Authors:  Wenjing Wang; Banghe Bao; Anbin Hu; Xiaofeng Zhu; Qing Chen
Journal:  AME Case Rep       Date:  2021-04-25

2.  Primary Mesenchymal Tumors of the Thyroid Gland: A Modern Retrospective Cohort Including the First Case of TFE3-Translocated Malignant Perivascular Epithelioid Cell Tumor (PEComa).

Authors:  Lingxin Zhang; Daniel Lubin; John H Sinard; Brendan C Dickson; Cristina R Antonescu; Hao Wu; Roheena Z Panni; Snjezana Dogan; Brian R Untch; Ronald A Ghossein; Bin Xu
Journal:  Head Neck Pathol       Date:  2022-02-26

Review 3.  Primary solitary fibrous tumor of the thyroid gland: A review starting from a case report.

Authors:  Ion Negură; Victor Ianole; Radu Dănilă; Maria-Christina Ungureanu; Delia Gabriela Ciobanu Apostol
Journal:  Arch Clin Cases       Date:  2021-12-29

4.  Magnetic resonance imaging features of a solitary fibrous tumor of the vulva: a case report.

Authors:  Chuxin Lin; Xiangrong Yu
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

5.  Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.

Authors:  David Suster; Michael Michal; Michiya Nishino; Simonetta Piana; Massimo Bongiovanni; Olga Blatnik; Veronika Hájková; Nikola Ptáková; Michal Michal; Saul Suster
Journal:  Mod Pathol       Date:  2020-04-14       Impact factor: 7.842

6.  Extrapleural solitary fibrous tumor of the thyroid gland: A case report and review of literature.

Authors:  Yong Joon Suh; Jung Ho Park; Jae Hyeon Jeon; Sanchir-Erdene Bilegsaikhan
Journal:  World J Clin Cases       Date:  2020-02-26       Impact factor: 1.337

Review 7.  Solitary Fibrous Tumors of the Chest: An Analysis of Fifty Patients.

Authors:  Jingwen Zhang; Jumin Liu; Zhihao Zhang; Beizong Tian
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.